Targeting cholesterol metabolism to overcome Zanubrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma. // Medicine in Novel Technology and Devices. – URL: https://www.sciencedirect.com/science/article/pii/S2590093526000433?dgcid=rss_sd_all
Targeting cholesterol metabolism to overcome Zanubrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma. Medicine in Novel Technology and Devices. https://www.sciencedirect.com/science/article/pii/S2590093526000433?dgcid=rss_sd_all
“Targeting cholesterol metabolism to overcome Zanubrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma.” Medicine in Novel Technology and Devices.
@article{article58483,
title = {Targeting cholesterol metabolism to overcome Zanubrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma},
journal = {Medicine in Novel Technology and Devices},
url = {https://www.sciencedirect.com/science/article/pii/S2590093526000433?dgcid=rss_sd_all}
}
Nature Biomedical Engineering, Published online: 18 November 2026; doi:10.1038/s41551-026-01843-z Tumour-associated mucins induce the disassembly of a designer PEGylated paclitaxel-conjugated nanomedicine into small unimers that escape...
npj Regenerative Medicine, Published online: 17 November 2026; doi:10.1038/s41536-026-00524-4 Structure-based design of a decorin mimetic targeting TGF-β1